Corporate Corruption News Articles

Excerpts of key news articles on

Below are key excerpts of revealing news articles on corporate corruption from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

Note: Explore our full index to revealing excerpts of key major media news articles on dozens of engaging topics. And read excerpts from 20 of the most revealing news articles ever published.

The knee-jerk attitude that the U.S. is the best place on earth to be sick, fueled by the reputations of great institutions like the Mayo Clinic and by America's leadership in drug and technology development, is beginning to be challenged by rigorous international comparisons. There is increasing evidence that, despite justified pride in individual institutions and medical breakthroughs, the world's biggest medical spender isn't buying its citizens the longest, healthiest lives in the world. It's not just moviemakers and comics saying so. The dire message that the U.S. healthcare system is, by some measures, an also-ran on the worldwide stage is being delivered by doctors, researchers — even insurance industry giants. On screen, slamming U.S. medical care is coming of age with Michael Moore's documentary "Sicko." Through the eyes of people who have faced healthcare catastrophes, he tells graphic stories of the problems with America's system. Considerably more sobering are the warnings from an official at the National Institutes of Health, who declared in the May 16 issue of the Journal of the American Medical Assn. that the U.S. healthcare system is "a dysfunctional mess." Amid stacks of reports, all with ... measures of access, equity, efficiency and medical outcomes, two statistics stand out. The U.S. spends more on medical care than any other nation, and gets far less for it than many countries. The U.S. spends an annual $6,102 per person — more than any other country and more than twice the average of $2,571. Yet Americans have the 22nd highest life expectancy among those nations at 77.2 years. People in Japan, the world leader in longevity, live an average of 81.8 years.

Senators who raised millions of dollars in campaign donations from pharmaceutical interests secured industry-friendly changes to a landmark drug-safety bill. The bill, which passed 93-1, grants the Food and Drug Administration broad new authority to monitor the safety of drugs after they are approved. It addressed some shortcomings that allowed the painkiller Vioxx to stay on the market for years after initial signs that it could cause heart attacks. However, the powers granted to the FDA in the bill's original version were pared back during private meetings. And efforts to curb conflicts of interest among FDA advisers and allow consumers to buy cheaper drugs from other countries were defeated in close votes. A measure that blocked an effort to allow drug importation passed, 49-40. The 49 senators who voted against drug importation received about $5 million from industry executives and political action committees since 2001 — nearly three quarters of the industry donations to current members of the Senate. Sen. Bernie Sanders, I-Vt. [was] the lone vote against the bill. "You have a culture in which big money has significant influence. Big money gains you access, access gives you the time to influence people." The pharmaceutical companies spend more money on lobbying than any other single industry — $855 million from 1998 to 2006. The biggest drug trade group, Pharmaceutical Research and Manufacturers of America, praised the bill after it passed. The group's spokesman, Ken Johnson, said its critics "never point out that a great deal of this money is spent trying to defeat bills … that are designed to cripple this industry."

Note: For lots more reliable, verifiable information on drug company manipulations, click here.

Highly educated workers have done better than those with less education, but a college degree has hardly been a ticket to big income gains. The 2006 Economic Report of the President tells us that the real earnings of college graduates actually fell more than 5 percent between 2000 and 2004. So who are the winners from rising inequality? It's not the top 20 percent, or even the top 10 percent. The big gains have gone to a much smaller, much richer group than that. A new research paper by Ian Dew-Becker and Robert Gordon of Northwestern University, "Where Did the Productivity Growth Go?," gives the details. Between 1972 and 2001 the wage and salary income of Americans at the 90th percentile of the income distribution rose only 34 percent, or about 1 percent per year. So being in the top 10 percent of the income distribution, like being a college graduate, wasn't a ticket to big income gains. But income at the 99th percentile rose 87 percent; income at the 99.9th percentile rose 181 percent; and income at the 99.99th percentile rose 497 percent. Should we be worried about the increasingly oligarchic nature of American society? Yes, and not just because a rising economic tide has failed to lift most boats. Both history and modern experience tell us that highly unequal societies also tend to be highly corrupt.

Note: If the above link fails, click here.

Exxon Mobil, the nation's largest energy company, today reported a 27 percent surge in profits for the fourth quarter as elevated fuel prices gave rise to the most lucrative year ever for an American company. Exxon's profits are expected to generate new scrutiny of the company's operations in Washington, where legislators have recently expressed concern over Big Oil's good fortune as soaring oil and natural gas prices pressure consumers. Exxon said its profits climbed more than 40 percent last year, while its tax bill rose only 14 percent. Exxon's revenue last year allowed it to surpass Wal-Mart as the largest company in the United States. [The company's] revenue of $371 billion surpassed the gross domestic product of $245 billion for Indonesia, an OPEC member and the world's fourth most populous country with 242 million people.

Note: This article fails to mention the huge profits reaped by oil companies as a result of gas price gouging immediately after Katrina.

In a case that echoes the Jack Abramoff influence-peddling scandal, two Northern California Republican congressmen used their official positions to try to stop a federal investigation of a wealthy Texas businessman who provided them with political contributions. Reps. John T. Doolittle and Richard W. Pombo joined forces with former House Majority Leader Tom DeLay of Texas to oppose an investigation by federal banking regulators into the affairs of Houston millionaire Charles Hurwitz, documents recently obtained by The Times show. The Federal Deposit Insurance Corp. was seeking $300 million from Hurwitz for his role in the collapse of a Texas savings and loan that cost taxpayers $1.6 billion. The investigation was ultimately dropped. Doolittle and Pombo — both considered protégés of DeLay — used their power as members of the House Resources Committee to subpoena the agency's confidential records on the case, including details of the evidence FDIC investigators had compiled on Hurwitz. Then, in 2001, the two congressmen inserted many of the sensitive documents into the Congressional Record, making them public and accessible to Hurwitz's lawyers, a move that FDIC officials said damaged the government's ability to pursue the banker. The FDIC's chief spokesman characterized what Doolittle and Pombo did as "a seamy abuse of the legislative process."

Companies with ties to the Bush White House and the former head of FEMA are clinching some of the administration's first disaster relief and reconstruction contracts in the aftermath of Hurricane Katrina. At least two major corporate clients of lobbyist Joe Allbaugh, President Bush's former campaign manager and a former head of the Federal Emergency Management Agency, have already been tapped to start recovery work along the battered Gulf Coast. One is...Halliburton Co. (Research) subsidiary Kellogg Brown and Root. Vice President Dick Cheney is a former head of Halliburton. Allbaugh formally registered as a lobbyist for Halliburton subsidiary Kellogg Brown and Root in February. Allbaugh is also a friend of Michael Brown, director of FEMA who was removed as head of Katrina disaster relief and sent back to Washington amid allegations he had padded his resume. Halliburton continues to be a source of income for Cheney, who served as its chief executive officer from 1995 until 2000. According to tax filings released in April, Cheney's income included $194,852 in deferred pay from the company.

The maker of a billion-dollar antipsychotic medication has acknowledged misleading doctors and other healthcare providers about the safety of its product, minimizing potentially deadly side effects. On Wednesday, drug maker Janssen Pharmaceutica wrote a two-page letter to doctors, warning them that the company, in promotional material, had "minimized potentially fatal risks, and made misleading claims" that the medication was more safe in treating mental illness than other drugs in the same category. Risperdal is the leading drug used to combat schizophrenia and other types of psychotic disorders, earning Janssen about $2.1 billion in annual sales. The drug was first marketed about eight years ago, and is prescribed to more than 10 million people worldwide. The "important correction of drug information" came shortly after federal regulators had accused Janssen of "disseminating" advertising and marketing material that was "false or misleading."

Don't miss the highly revealing article on this vital topic by the New England Journal of Medicine's former editor in chief Marica Angell. Click here

Rats fed on a diet rich in genetically modified corn developed abnormalities to internal organs and changes to their blood, raising fears that human health could be affected by eating GM food. Details of secret research carried out by Monsanto, the GM food giant...shows that rats fed the modified corn had smaller kidneys and variations in the composition of their blood. According to the confidential 1,139-page report, these health problems were absent from another batch of rodents fed non-GM food. Although Monsanto last night dismissed the abnormalities in rats as meaningless and due to chance...a senior British government source said ministers were so worried by the findings that they had called for further information. The full details of the rat research are included in the main report, which Monsanto refuses to release on the grounds that "it contains confidential business information which could be of commercial use to our competitors".

Note: For lots more reliable, verifiable information on this vital topic, see our summary of Seeds of Deception.

Dr. Walter Bernard Coffey of San Francisco was again asking the State of New York's Department of Social Welfare permission to open a cancer research laboratory and clinic at Huntington, L. I. His cohorts surrounded him. Opposed were Dr. John Augustus Hartwell, president of the New York Academy of Medicine, spokesman for organized Medicine, and his cohorts. The simple question was: Should the State authorize the cancer clinic? But in the train of that simple question came a most extraordinary range of considerations—the nature and cause of cancer; the nature and authenticity of the Coffey-Humber cancer treatment; medical ethics, human nature, public policy, money, fame, and even national politics. Dr. Coffey ... is chief surgeon of Southern Pacific Co. He has 600 doctors working under him. They care for 70,000 railroad men and their families. Dr. John Augustus Hartwell, 61, president of the New York Academy of Medicine ... and most of his associates want Drs. Coffey & Humber and their cancer extract kept away from New York. They fear that the hope of a Coffey-Humber cancer cure will persuade the cancerous to abandon the orthodox treatment of surgery, X-rays and radium. Very quickly after a sufferer gets a Coffey-Humber injection, his pain quiets, and in 71% of the cases disappears. In most of the cases who do not die (Drs. Coffey & Humber will treat only the moribund, cases rejected as hopeless by at least two reputable doctors), the cancer becomes necrotic, ceases to smell, and sloughs off leaving a clean hole. That undeniably happens. Why that happens is debatable.

Note: To read how permission for the innovative cancer clinic was eventually refused, click here. If you want to understand how politics and big money prevented the legitimate study of promising cancer cures back in the 1930s, this article is a highly revealing "must read."

Ecuador's highest court has upheld a $9.5 billion judgment against oil giant Chevron for decades of rainforest damage. Plaintiffs celebrated the constitutional court's decision announced Tuesday night, saying it should pave the way for indigenous tribes to receive compensation for oil spills that contaminated groundwater and soil in their Amazon home. But the ruling is largely symbolic as Chevron no longer operates in the South American country. That means Ecuador's government will have to pursue assets owned by the ... company in foreign courts, where it so far has had little luck. Last week, an appeals court in Argentina rejected an attempt by Ecuador to collect on its award, echoing earlier rulings by courts in Canada, Gibraltar and Brazil. In 2014, a U.S. court of appeals ... also denied Ecuador's request, arguing that the original judgment was obtained through bribery, coercion and fraud. In an added twist, the American lawyer who for years represented Ecuador in the matter was barred Tuesday from practicing law in New York state. The New York state appeals court found Steven Donziger guilty of professional misconduct, saying that in his appeal of the 2014 ruling he did not challenge the judge's findings of bribery, witness tampering, and the ghostwriting of a court opinion.

Note: For more along these lines, see concise summaries of deeply revealing corporate corruption news articles from reliable major media sources.

Evidence that Roundup weed killer can cause cancer seems "weak," but experts can still make that claim at trial, a U.S. judge ruled Tuesday. The decision by U.S. District Judge Vince Chhabria in San Francisco allows hundreds of lawsuits against Roundup's manufacturer, Monsanto, to move forward. The lawsuits by cancer victims and their families say the agrochemical giant long knew about Roundup's cancer risk but failed to warn them. The judge wanted to determine whether the science behind the claim that Roundup can cause non-Hodgkin's lymphoma had been properly tested and met other requirements to be considered valid. Before issuing his ruling, Chhabria spent a week in March hearing dueling testimony from epidemiologists. He peppered them with questions about potential strengths and weaknesses of research on the cancer risk of glyphosate. Beate Ritz, an epidemiologist at the University of California, Los Angeles, testified for the plaintiffs that her review of scientific literature led her to conclude that glyphosate and glyphosate-based compounds such as Roundup can cause non-Hodgkin's lymphoma. Ritz said a 2017 National Institute of Health study that found no association between glyphosate and non-Hodgkin's lymphoma had major flaws. A federal judge in Sacramento in February blocked California from requiring that Roundup carry a label stating that it is known to cause cancer.

Note: As major lawsuits like this one against Monsanto unfold, the EPA continues to use industry studies to declare Roundup safe while ignoring independent scientists. A recent independent study published in a scientific journal found a link between glyphosate and gluten intolerance. Internal FDA emails suggest that the food supply contains far more glyphosate than government reports indicate. For more along these lines, see concise summaries of deeply revealing news articles on food system corruption and health.

Pharmaceutical companies that spend billions of dollars to develop new drugs do not want competitors to profit from inexpensive generic copies of blockbuster medicines. To avoid rivals, they ... sometimes prevent generic drug companies from obtaining samples. Dr. Scott Gottlieb, the commissioner of the Food and Drug Administration, calls this “gaming the system,” and has vowed to stop it. On Thursday, the F.D.A. took a new tack and began posting a list of makers of brand-name drugs that have been the target of complaints, to persuade them to “end the shenanigans,” in the commissioner’s words. Congressional efforts to force the companies to hand over samples of their drugs to generic competitors have not been successful. Generic drug developers usually need between 1,500 to 5,000 units of the brand drug to develop their product and test it. Both the F.D.A. and the Federal Trade Commission say securing the samples can be difficult. The F.D.A.’s new list includes drug companies the agency said may be pursuing gaming tactics to delay generic competition. Along with the name of each business, the agency noted how many inquiries it received from generic drug companies seeking supplies. Celgene, [which makes drugs to treat cancer and immune-inflammatory diseases], tops the list. Other companies ... included GlaxoSmithKline, Pfizer, Valeant Pharmaceuticals International, BioMarin Pharmaceutical, Gilead Sciences and Novartis Pharmaceuticals.

Note: For more along these lines, see concise summaries of deeply revealing Big Pharma corruption news articles from reliable major media sources.

A group of student activists sat in the library at George Mason University this past week feeling both vindicated and violated. The group, Transparent GMU, had sued ... last year after it was denied requests for documents that it suspected showed how deep-pocket donors were given undue influence over academic affairs. After a recent court hearing in the case, the university released those documents. The documents reveal in surprising detail that for years, as George Mason grew from a little-known commuter school to a major public university and a center of libertarian scholarship, millions of dollars in donations from conservative-leaning donors like the Charles Koch Foundation had come with strings attached. As early as 1990, entities controlled by the billionaire brothers Charles G. and David H. Koch were given a seat on a committee to pick candidates for a professorship that they funded. Similar arrangements that continued through 2009 gave donors decision-making roles in selecting candidates for key economics appointments. In 2016, executives of the Federalist Society, a conservative national organization of lawyers, served as agents for a $20 million gift from an anonymous donor, and were given the right to terminate installments of the gift at their discretion. Federalist Society officials were also involved in hiring discussions and had suggested a student for admission. In academia, such influence is viewed as inappropriate.

Note: The above article suggests that the secretive empire built by the Koch brothers to manipulate US politics extends deep into academia. For more along these lines, see concise summaries of deeply revealing corporate corruption news articles from reliable major media sources.

The largest dead zone ever recorded in the U.S. has appeared at the mouth of the Mississippi River. According to scientists, it's primarily caused by fertilizer and sewage that wash off farmland in the river's watershed and eventually make their way to the sea. Scientists announced this month the dead zone measures nearly 9,000 square miles – about the size of New Jersey. Underwater video recorded Tuesday afternoon shows the transition from life to death as green fades to black. It becomes so dark, divers need flashlights to find their way around. The abyss stretches over an enormous portion of the Gulf. "This is the largest one we've ever measured. And the northern Gulf of Mexico dead zone is the second largest human-caused dead zone in the ocean," said Nancy Rabalais, the nation's foremost expert on dead zones. She's been measuring oxygen levels in the Gulf since 1985. Dead zones happen when agricultural runoff sends nitrogen-rich fertilizer downstream into the sea. The fertilizer feeds harmful amounts of algae at the surface that eventually die and sink to the bottom. Bacteria feast on the dead algae, removing oxygen from the water. "The solution lies upstream in the watershed with better agricultural management practices - a switch to crops that have deeper roots and don't need as much fertilizer," Rabalais said.

Note: For more along these lines, see concise summaries of deeply revealing news articles on food system corruption and mass animal deaths.

Martin Shkreli - famously known as the guy that jacked up the price of a lifesaving AIDS treatment by 5,000% - finally saw his day in court, albeit for a completely unrelated case involving an unrelated company. The trial ... found Shkreli guilty of three counts of fraud for essentially lying to his investors about how he would invest their money and when they would be paid back. The conviction, carrying a potential 20 years in prison, is no joke. Yet the notorious self-promoter took the opportunity to ... let the world know he wasn’t fazed. And why should he be? How Shkreli got rich in the first place remains not just legal but celebrated. The real crime of the Pharma Bro is the unrepentant greed that drives him, as well as the industry he’s thrived in. Sen. Bernie Sanders has attempted to put a stop to this greed with recently introduced legislation to cap prices for pharmaceuticals developed by government-funded research. Far from a new idea, Sanders has been pushing for a bill like this for decades. While raising the price of a life-saving drug by 5,000% rightfully drew the scorn of millions of people, price gouging is all too common for the industry. Take the EpiPen, the lifesaving device for kids and adults with severe allergies, whose price was famously hiked up over 500% ... after it was acquired by Mylan. Laws that protect investors in these companies are what landed Shkreli in court. Yet until there are laws to protect patients from drug company extortion, like the one proposed by Sanders, the line of Pharma Bros ready to take his place is already queued up.

Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma profiteering and corporate corruption.

Since 2000, the number of overdose deaths from drugs in the U.S. has risen more than 137%. Deaths from opioids - which include painkillers and heroin - make up a large portion of these deaths; 91 Americans die every day from an opioid overdose. Federal numbers like these reveal a dire situation. But a new study finds that many opioid-related deaths are underreported, and that the full picture of the epidemic may be worse than even those numbers show. In the report, Christopher Ruhm, a professor of public policy & economics at the University of Virginia ... found that nationwide, the death rate from opioids is 24% higher than what has been estimated previously. Deaths related to heroin, which is cheaper than prescription painkillers, are 22% higher, he says. When hospitals enter the cause of death on a person’s death certificate, the drugs that contributed might not be specified, or multiple drugs will be listed as present. Between 20%-25% of the overdose death certificates Ruhm studied did not have any drug specified, suggesting that statewide estimates of deaths linked to opioids could be significantly off. Ruhm found that the overall death rates from opioids were substantially underreported across the U.S. - by more than half in Pennsylvania, for example. The growth in death rates from 2008 to 2014 - the time period Ruhm studied - was also substantially underestimated in many states.

Note: The city of Everett, Washington is currently suing Purdue Pharma, maker of the opioid pain medication OxyContin, for the company's alleged role in the diversion of its pills to black market buyers. For other reliable information on pharmaceutical involvement in the huge increase in opioid deaths, see Dr. Mercola's excellent article. For more along these lines, see concise summaries of deeply revealing pharmaceutical corruption news articles from reliable major media sources.

The global meat industry, already implicated in driving global warming and deforestation, has now been blamed for fueling what is expected to be the worst “dead zone” on record in the Gulf of Mexico. Toxins from manure and fertiliser pouring into waterways are exacerbating huge, harmful algal blooms that create oxygen-deprived stretches of the gulf, the Great Lakes and Chesapeake Bay, according to a new report by Mighty, an environmental group chaired by former congressman Henry Waxman. The National Oceanic and Atmospheric Administration (Noaa) will this week announce the largest ever recorded dead zone in the Gulf of Mexico. It is expected to be larger than the nearly 8,200 square-mile area that was forecast for July. “This problem is worsening and worsening and regulation isn’t reducing the scope of this pollution,” said Lucia von Reusner, campaign director at Mighty. “These companies’ practices need to be far more sustainable.” The Mighty report analyzed supply chains of agribusiness and pollution trends and found that a “highly industrialized and centralized factory farm system” was ... bringing fertilisers into waterways. Tyson Foods is identified by the report as a “dominant” influence in the pollution. This pollution has also been linked to drinking water contamination. Last week, a report by Environmental Working Group found that in 2015 water systems serving seven million Americans in 48 states contained high levels of nitrates ... linked to an increased risk of contracting certain cancers.

Note: For more along these lines, see concise summaries of deeply revealing news articles on food system corruption and mass animal deaths.

Google spent the most it ever has in a single quarter trying to influence elected officials in Washington, according to lobbying disclosures made public late Thursday. The past three months have also seen record spending on lobbying by several other major tech companies, including Amazon, Apple and Uber. Google Inc., according to the disclosure forms, spent $5.93 million between April 1 and June 30. That’s about 40 percent more than it had spent during the same period last year. The only three entities that doled out more money were large business organizations: the U.S. Chamber of Commerce ($11.68 million), the National Association of Realtors ($10.92 million) and Pharmaceutical Research and Manufacturers of America ($6 million). Since the 2016 election, the tech industry has had to navigate ... an administration whose decisions have often cut against Silicon Valley’s business interests. The combined lobbying efforts of some of the most influential tech companies - Google, Facebook, Amazon, Apple and Microsoft - totaled $15.79 million. Google’s lobbying efforts come as it faces the largest fine the European Union has ever levied against a company for abusing its dominant market position. In June, the European Union’s antitrust chief hit Google with a $2.7 billion fine, saying the company illegally steered users toward its comparison shopping site. If the ruling is not overturned, it could reshape the company’s behavior and direct the evolving boundaries of tech-industry regulation.

Note: Check out the intriguing, well researched article "How the CIA Made Google." For more along these lines, see concise summaries of deeply revealing corporate corruption news articles from reliable major media sources.

The White House disclosed Wednesday evening that it has granted ethics waivers to 17 specific appointees who work for President Donald Trump and Vice President Mike Pence, including four former lobbyists. The waivers exempt the appointees from certain portions of ethics rules aimed at barring potential conflicts of interest. In addition, a blanket waiver was given to all executive office appointees to interact with news organisations. Three of the former lobbyists given waivers to work in the White House serve as staffers to the National Economic Council, headed by former Goldman Sachs executive Gary Cohn. (Cohn himself did not need a waiver because he recuses himself from participating in matters specific to Goldman Sachs, according to a White House official.) His aides that received ethics exemptions include Michael Catanzaro, a domestic energy and environmental policy adviser. Catanzaro was granted permission to work on ... matters of interest to his former energy sector clients, including emissions regulations, clear air standards and renewable fuel standards. Shahira Knight, a White House adviser on tax and retirement policy, received a waiver to participate in a range of tax and financial policy matters. Knight, a former tax lobbyist, served as vice president of Fidelity Investments' public affairs and policy group. Trump's predecessors also issued ethics waivers to appointees who had potential conflicts of interest. The Obama administration handed out at least 66 such exemptions.

Note: Despite the White House's assurances to the contrary, the NEC's Gary Cohn is reportedly spearheading a plan to sell US infrastructure to large financial firms, including his former employer Goldman Sachs. For more along these lines, see concise summaries of deeply revealing government corruption news articles from reliable major media sources.

The federal government sued UnitedHealth Group on Tuesday alleging the Minnetonka-based health care company wrongly received from Medicare at least $1 billion in “risk adjustment” payments based on inaccurate data submissions. The federal government’s civil fraud action comes in a whistleblower case first brought by a former UnitedHealth Group employee. Earlier this year, the federal government disclosed it had ongoing investigations about risk adjustment practices at four other carriers including Aetna and a division of Cigna. In Medicare Advantage plans, the government pays health insurers a per-member per-month payment for enrollees. The government says the fees can be increased when health plans submit information about an enrollee’s health that justifies a higher “risk score” for the patient. The federal lawsuit filed Tuesday highlighted UnitedHealth’s program to review charts, calling it a “one-sided revenue-generating program.” The insurer collected “millions of medical records” and employed chart reviewers “in order to mine for diagnoses that the providers themselves did not report to United for their patients,” the lawsuit states. “United used the results of the chart reviews to only increase government payments ... while in bad faith systematically ignoring other information from the chart reviews which would have led to decreased payments.”

Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and health.

Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.